Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1.
about
Raf-1 physically interacts with Rb and regulates its function: a link between mitogenic signaling and cell cycle regulationTargeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyondMEKK1 phosphorylates MEK1 and MEK2 but does not cause activation of mitogen-activated protein kinaseConditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cellsMembrane initiated estrogen signaling in breast cancer.Suppression of integrin activation by activated Ras or Raf does not correlate with bulk activation of ERK MAP kinase.A novel mitogen-activated protein kinase is responsive to Raf and mediates growth factor specificity.Induction of beta3-integrin gene expression by sustained activation of the Ras-regulated Raf-MEK-extracellular signal-regulated kinase signaling pathway.Inhibition of a signaling pathway in cardiac muscle cells by active mitogen-activated protein kinase kinaseGrowth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins.Regulation of Raf-1-dependent signaling during early Xenopus development.Raf, but not MEK or ERK, is sufficient for differentiation of hippocampal neuronal cells.Induction of cell proliferation in quiescent NIH 3T3 cells by oncogenic c-Raf-1.Differentiation of central nervous system neuronal cells by fibroblast-derived growth factor requires at least two signaling pathways: roles for Ras and SrcRaf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1.Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis.Cooperation of protein kinase A and Ras/ERK signaling pathways is required for AP-1-mediated activation of fibroblast growth factor-inducible response element (FiRE).Rapid phosphorylation of Ets-2 accompanies mitogen-activated protein kinase activation and the induction of heparin-binding epidermal growth factor gene expression by oncogenic Raf-1.High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1.Prolonged activation of ERK1,2 induces FADD-independent caspase 8 activation and cell death.The mammalian mitogen activated protein kinase network.Repression of mitogen-activated protein kinases ERK1/ERK2 activity by a protein tyrosine phosphatase in rat fibroblasts transformed by upstream oncoproteins.Oncogenic raf-1 induces the expression of non-histone chromosomal architectural protein HMGI-C via a p44/p42 mitogen-activated protein kinase-dependent pathway in salivary epithelial cells.Oncogenic Raf-1 activates p70 S6 kinase via a mitogen-activated protein kinase-independent pathway.Differential modulation of mitogen-activated protein (MAP) kinase/extracellular signal-related kinase kinase and MAP kinase activities by a mutant epidermal growth factor receptor.Protein kinase A balances the growth factor-induced Ras/ERK signaling.Role of the Raf/mitogen-activated protein kinase pathway in p21ras desensitization.Phospholipase D overcomes cell cycle arrest induced by high-intensity Raf signaling.An analysis of Mek1 signaling in cell proliferation and transformation.Characterization of a uterine luminal fluid protein ULF-250 using N-terminal microsequencing and RT-PCR identifies a novel estrogen-regulated gene in the rat uterus.
P2860
Q24522903-5F97916F-78BE-4321-B037-916EBF6A8A9AQ27026323-729F9276-0D24-4F8C-805E-E9EFF5CC5BB2Q28581201-BFA95062-1C9B-4B02-9D9E-AC7DA9FAE745Q28609131-07026FB8-EF16-4883-9695-86817FB26A1AQ30439994-F9BE82FE-BB3C-4324-BFD4-99B0FFE0B19EQ33893431-C75346C8-D7D2-43FF-A990-AB8B16DCF3D1Q33967754-8B09AB8F-1263-4B4A-AC4C-E5FA358EBF9DQ33968056-366804A6-EC72-4926-A236-7D15909C3E32Q34452835-9ACE26B3-8BCA-4B12-A4E4-ADC68FADFC50Q36288233-72E574B0-30F9-46FC-A5A2-86A81F967AABQ36556197-A636A1A6-B820-42FA-A0C4-3A8700258258Q36557848-5C625CA6-B717-4C17-91E8-F1FCC7178978Q36568076-628C6802-7A68-4A8B-8860-CA0EEDA8B14AQ36570448-DA1D9D98-324B-4495-8384-F646F6D32EFAQ36572588-505727DF-2392-416C-B0F6-25DADDF79E40Q37380645-0C15F9F2-9B67-4106-AC0C-39647A3326DCQ37630591-82733209-9320-4D92-9807-AAD1323245CEQ38289383-733AA1F9-A3B8-4AB4-9470-1EFB59467B24Q40022010-B05363E2-7C77-43DD-A845-FC5019E4AA8CQ40023426-E12D771A-39C7-4D66-8207-93264D56739EQ40304758-6B3614DF-E108-4593-B2D6-091F55392168Q40849045-BBE295E1-2A91-4267-AA03-F6852E3C07C6Q41076956-979C6E02-0C2A-439A-806B-57B1AB70521AQ41089150-BBDDE135-FE21-4B9D-B1B6-1F9D3DD93CAFQ41190428-0BD7B48B-C235-4C34-BE1A-8E1FAC0F0C07Q42512929-59146AF4-BF92-496F-A422-D803EE8C054DQ42522435-94FAC0D7-2825-4D5E-A480-E3E6132D344BQ42811065-D421CE02-5FC0-41F7-90A0-3164AD7EB9A2Q42814716-5B6510D6-63FE-49A5-9C9A-169A19ACD487Q42829980-DC1FA2F5-C5D1-4731-A116-B55917310473Q48056842-8E604036-9F33-429F-9804-3A8037278E8B
P2860
Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Inhibition of platelet-derived ...... adiol-regulated form of Raf-1.
@ast
Inhibition of platelet-derived ...... adiol-regulated form of Raf-1.
@en
type
label
Inhibition of platelet-derived ...... adiol-regulated form of Raf-1.
@ast
Inhibition of platelet-derived ...... adiol-regulated form of Raf-1.
@en
prefLabel
Inhibition of platelet-derived ...... adiol-regulated form of Raf-1.
@ast
Inhibition of platelet-derived ...... adiol-regulated form of Raf-1.
@en
P2860
P356
P1476
Inhibition of platelet-derived ...... adiol-regulated form of Raf-1.
@en
P2093
P2860
P304
P356
10.1128/MCB.14.12.7855
P407
P577
1994-12-01T00:00:00Z